It has also been suggested to confirm the lack of response to second-generation antihistamines and mast cell–targeted therapies in patients with clinical suspicion of HAE and normal antigenic C4, antigenic C1INH, and fC1INH levels.37 The gene discussed is SERPING1; the disease is hereditary angioedema.